No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Widex introduces My Sound: A New Portfolio of AI-enabled Features for Customization of Its Industry-leading Widex MOMENT™ Hearing Aids

Editor: What To Know

  • “Instead of having to program the hearing aid in a way that covers all situations the user might encounter, the hearing care professional ensures the best possible starting point for the user and My Sound then allows users to personalize their experience in real life, easily and instantly.
  • Building on the success of the revolutionary, artificial intelligence-based SoundSense Learn technology, the company announced Widex My Sound, a portfolio of AI features including a new solution that instantly enables intelligent customization of the company's cutting-edge Widex MOMENT hearing aids based on a users' activity and listening intent.
  • Through AI modeling and clustering of data collected via the Widex SoundSense Learn AI engine, highly qualified sound profile recommendations for the individual user can now be made based on the intent, need, and preferences of thousands of users in similar real-world situations.

Widex reports: Building on the success of the revolutionary, artificial intelligence-based SoundSense Learn technology, the company announced Widex My Sound, a portfolio of AI features including a new solution that instantly enables intelligent customization of the company’s cutting-edge Widex MOMENT hearing aids based on a users’ activity and listening intent.

Widex was the first company to enable user-driven sound personalization by leveraging artificial intelligence in hearing aids. Now, within My Sound, Widex launches the third generation of its AI technology, vastly improving the usability of the AI solution based on the extensive data the company has gathered from the previous two generations.

This new AI solution further combines the capacity of artificial intelligence with users’ personal real-world experience to deliver another level of automated customization. Through AI modeling and clustering of data collected via the Widex SoundSense Learn AI engine, highly qualified sound profile recommendations for the individual user can now be made based on the intent, need, and preferences of thousands of users in similar real-world situations.

“Widex is leading the industry by combining artificial intelligence and human intelligence to create natural sound experiences and foster social participation through better hearing,” said Jodi Sasaki-Miraglia, AuD, Widex’s Director of Professional Training and Education. “Once Widex Moment is fit properly by a local licensed hearing care professional, the user can, if necessary, customize their hearing aids with ease, choosing from multiple AI features. Plus, our latest generation delivers results in just seconds, putting control and intelligent personalization into the hands of every user.”

My Sound is integrated into the Widex MOMENT app and is the home for all the powerful AI personalization Widex offers. The latest generation of AI utilizes the cloud-based user data of Widex users worldwide to make sound profile recommendations based on an individual user’s current activity and listening intent. Users launch My Sound from the app and begin by selecting their activity, such as dining, then choosing their intent, such as socializing, conversation, or enjoying music.

Based on the user’s selections, Widex can draw on tens of thousands of real-life data points, reflecting the preferences and listening situations of other Widex users who have used the app previously. In seconds, the user is presented with two recommendations, which can both be listened to before selecting the settings that sound best. In the event neither recommendation meets the individual user’s needs, they can launch SoundSense Learn from the same screen to further personalize their hearing experience through that solution’s sophisticated A/B testing process.

Widex has created a radically different way of delivering hearing solutions for today’s active hearing aid user,” Sasaki-Miraglia continued. “Instead of having to program the hearing aid in a way that covers all situations the user might encounter, the hearing care professional ensures the best possible starting point for the user and My Sound then allows users to personalize their experience in real life, easily and instantly. In this way, the hearing solution adapts to the user’s preferences and becomes even more personal.”

The Widex MOMENT app, including My Sound with SoundSense Learn, is available for Apple and Android devices and is designed to work with Widex MOMENT Bluetooth hearing aids.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy